Stockscreener 앱 받기
28.58
1.04%
-0.30
Simulations Plus Inc 주식(SLP)의 최신 뉴스
Simulations Plus's SWOT analysis: bio-simulation leader faces growth hurdles - Investing.com
Simulations Plus (SLP) Sets Q1 FY2025 Earnings Release DateKey Financial Results Coming January 7 - StockTitan
Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date - Marketscreener.com
(SLP) Trading Report - Stock Traders Daily
Charles Schwab Investment Management Inc. Sells 989 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
US Growth Stocks With High Insider Ownership For December 2024 - Simply Wall St
Brokerages Set Simulations Plus, Inc. (NASDAQ:SLP) PT at $51.40 - MarketBeat
Biosimulation Industry Forecast, 2029: Analysis of Case Studies, Market Dynamics, Regional Growth Trends, Regulatory Landscape, Value Chain, and Competitive Intelligence - GlobeNewswire Inc.
Simulations Plus's SWOT analysis: bio-simulation leader's stock faces growth hurdles - Investing.com Nigeria
BNP Paribas Financial Markets Has $1.28 Million Stock Position in Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
BNP Paribas Financial Markets Grows Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
1,842 Shares in Simulations Plus, Inc. (NASDAQ:SLP) Bought by Quantbot Technologies LP - Defense World
(SLP) Investment Report - Stock Traders Daily
Thrivent Financial for Lutherans Cuts Stock Position in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
Insider Selling: Walter Woltosz Sells 20,000 Shares of Simulatio - GuruFocus.com
Simulations Plus, Inc.'s (NASDAQ:SLP) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance
Simulations Plus director Lisa LaVange sells $20,722 in stock By Investing.com - Investing.com Canada
Simulations Plus director Walter Woltosz sells $635,200 in stock By Investing.com - Investing.com Australia
Insider Sell: Lisa Lavange Sells Shares of Simulations Plus Inc (SLP) - GuruFocus.com
Simulations Plus director Walter Woltosz sells $635,200 in stock - Investing.com
Simulations Plus director Lisa LaVange sells $20,722 in stock - Investing.com
Wasatch Advisors LP Sells 66,061 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Computational Toxicology Software Market May Set a New Epic Growth Story with Simulations Plus - Newstrail
ARB IOT Group (NASDAQ:ARBB) versus Simulations Plus (NASDAQ:SLP) Critical Analysis - Defense World
Wall Street Analysts Predict a 56.99% Upside in Simulations Plus (SLP): Here's What You Should Know - MSN
JMP Securities Initiates Coverage of Simulations Plus (SLP) with Market Perform Recommendation - MSN
Simulations Plus (NASDAQ:SLP) Stock Price Up 7.8%Here's Why - MarketBeat
Principal Financial Group Inc. Buys 2,226 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
Detailed Analysis of Molecular Modeling for Drug Development - openPR
Uncovering the Future: Pharmaceutical Simulation Software - openPR
Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar? - Yahoo Finance
Simulations Plus stock hits 52-week low at $27.2 amid market shifts - Investing.com Canada
Simulations Plus stock hits 52-week low at $27.2 amid market shifts By Investing.com - Investing.com South Africa
How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52% - MSN
Simulations Plus to Participate in the BTIG Digital Health Forum - BioSpace
Biosimulation Market Dynamics and Future Opportunities | 2024 - openPR
Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Rating of “Buy” by Brokerages - Defense World
Royce & Associates LP Acquires 53,092 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Receives $51.40 Average PT from Brokerages - MarketBeat
Simulations Plus (NASDAQ:SLP) Upgraded at Stephens - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Shares Bought by US Bancorp DE - Defense World
Simulations Plus (NASDAQ:SLP) Now Covered by Analysts at Stephens - MarketBeat
Where are the Opportunities in (SLP) - Stock Traders Daily
Simulations Plus Inc (SLP) Shares Gap Down to $30.515 on Nov 14 - GuruFocus.com
Simulations Plus Wins FDA Grant for Revolutionary Drug Delivery Modeling Technology | SLP Stock News - StockTitan
Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables - Business Wire
1.16%
0.30%
자본화:
|
볼륨(24시간):